• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Pre-operative magnetic resonance imaging may not improve contralateral breast cancer detection

byMonica ParksandDavid Wang
December 11, 2015
in Imaging and Intervention, Obstetrics, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

 

1. In a retrospective review of over 6000 patients with breast cancer, pre-operative breast magnetic resonance imaging (MRI) does not significant improve the detection of clinically significant contralateral breast cancers (CBC).

Evidence Rating Level: 3 (Average)

Study Rundown: In breast cancer patients, pre-operative MRI are commonly used for screening of CBCs. However, given the increased financial costs as well as the psychological stress of false-positive findings, it is unclear whether routine MRI scans in this patient population offer significant benefit. The purpose of this retrospective cohort study was to evaluate the effect of pre-operative MRI use on CBC incidence.

The study reviewed the 5-year outcomes data of over 6000 breast cancer patients that underwent pre-operative breast MRI scans and over 32 000 propensity-matched breast cancer patients that did not undergo pre-operative breast MRI. At the conclusion of the study, patients in the breast MRI group demonstrated an increased frequency of synchronous (<6 months after diagnosis) CBC diagnosis compared to the non-MRI group. However, using statistical prediction models, the majority of these cases were likely in-situ CBCs and stage I disease at 5-year follow-up. There was no significant association between breast MRI use and detection of stage II to IV CBC. The results of this study support the hypothesis that pre-operative MRI may not significant detected clinically significant CBC, which may lead to over-diagnosis. The study was limited to patients greater than 67 years of age; thus, the results are not generalizable to younger patients, who may benefit more from early diagnosis of CBCs. Additionally, the study focused only on CBC recurrences. Additional prospective trials in younger patients as well as ipsilateral disease recurrence are needed to clarify the role of pre-operative MRI in breast cancer patients.

Click to read the study in JCO

RELATED REPORTS

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

Vepdegestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

Relevant Reading: Overview of the role of pre-operative breast MRI in the absence of evidence in patient outcomes

In-Depth [retrospective cohort]: This study was a retrospective review on the incidence of CBC in breast cancer patients with or without pre-operative breast MRI scans. The study reviewed all patients with stage I to II breast cancer pages aged 67 to 94 from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database in the United States. Overall, the study reviewed 6737 breast cancer patients with pre-operative MRI and 32 234 propensity matched breast cancer patients that did not undergo MRI. At the conclusion of the study, the pre-operative MRI group demonstrated higher rate of synchronous in-situ CBC (47.9 vs 12.9 per 1000 person-years; p > 0.001) and invasive CBC (78.6 vs 30.0 per 1000 person-years; p > 0.001). In a Markov prediction model simulation, pre-operative breast MRI use was associated with increased detection of in-situ and early stage CBC occurrences without significant increase in detection of stage II to IV CBC cases.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast CancerMagnetic Resonance Imaging (MRI)
Previous Post

Mass administration of ivermectin may decrease prevalence of scabies and impetigo

Next Post

Gains in life expectancy linked with gains in health expectancy in old age

RelatedReports

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Endocrinology

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

August 28, 2025
One-year of Herceptin preferable to two-year regimen
Endocrinology

Vepdegestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

August 28, 2025
USPSTF recommends chemoprevention for women at high risk for breast cancer
Endocrinology

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

August 26, 2025
Incidental findings common with breast imaging, often benign
Chronic Disease

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women

August 21, 2025
Next Post
Increased risk of stillbirth recurrence after a previous stillbirth

Gains in life expectancy linked with gains in health expectancy in old age

Time from symptom onset may not predict infarct volume in stroke

Curriculum for patient-centered counseling not linked to reduced low-value testing

Reduced neuronal BRCA1 associated with decreased DNA repair in Alzheimer’s disease [PreClinical]

Reduced neuronal BRCA1 associated with decreased DNA repair in Alzheimer's disease [PreClinical]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Measurement-Based Care to Enhance Antidepressant Treatment Outcomes in Major Depressive Disorder: A Randomized Clinical Trial
  • Natural language processing (NLP) model sped up patient message management in the electronic health record (EHR)
  • Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.